Le Lézard
Classified in: Science and technology
Subjects: CCA, ACC, FVT

ASETEK - Notice of Extraordinary General Meeting December 5, 2023


AALBORG, Denmark, Nov. 10, 2023 /PRNewswire/ -- The Board of Directors of Asetek A/S hereby gives notice of an extraordinary general meeting to be held on December 5, 2023, at 10:00 AM CET. The extraordinary meeting is held at Asetek's office at Assensvej 2, 9220 Aalborg.

The notice convening the general meeting, the agenda, and the full text of the proposal can be downloaded from website https://ir.asetek.com/EGM22023.

The notice to convene the extraordinary general meeting and proxy / postal vote are enclosed.

On the day of the notice of the general meeting there are 98,313,892 shares and 98,313,892 voting rights in Asetek A/S. 

For questions or further information, please contact:

CFO, Peter Dam Madsen, +45 2080 7200, email: [email protected]

Head of Investor Relations, Per Anders Nyman, +45 2566 6869, email: [email protected]

This information is subject to the disclosure requirements pursuant to Section 5 -12 of the Norwegian Securities Trading Act. This stock exchange release was published by Per-Anders Nyman, Head of Investor Relations, on November 10, 2023 at 10:00 AM CET.

The following files are available for download:

https://mb.cision.com/Main/6758/3872906/2420699.pdf

Notice of extraordinary general meeting 2023_Delisting

 

SOURCE Asetek


These press releases may also interest you

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

at 11:10
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...



News published on and distributed by: